Dehydronandrolon acetate is a key intermediate for the synthesis of (faslodex) und , while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, langanhaltender Muskelaufbau. This is because of the relatively long half-life of the …